- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT04938791
Fatigue and Kinematics During Isometric Activity of the Upper Limbs in Young and Older Adults
Relationship Between Perceive Effort, Physiological and Kinematic Changes During Upper Limbs Isometric Activity and Its Relationship With the Socio-demographic Characteristics
Обзор исследования
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
-
Lisboa, Португалия, 1300-125
- Escola Superior de Saúde da Cruz Vermelha Portuguesa - Lisboa
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Healthy
- Minimum age of 18 years;
Exclusion Criteria:
- Unable to provide written consent
- History of heart, cardiovascular and / or respiratory disease,
- Known untreated hypertension, cardiomyopathy, or exercise intolerance
- Presence of cognitive or neurological disorders
- Neuromuscular or orthopaedic disorder that limits the movement of the upper limb to 90° flexion or the maintenance of that position
- BMI ≥ 40
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Фундаментальная наука
- Распределение: Н/Д
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Isometric activity
All participants will be included in this arm
|
Participants will do elevation of upper limbs and mantain a 90º degree flexion position in an unsupported way.
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change from Baseline in perceived effort on the Borg category-ratio 10-point scale (CR 10)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
The perceived effort will be measured with Borg CR 10 scale.
Possible scores range from 0 (no exertion at all) to 10 (extremely strong).
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Heart rate (heart beatings per minute) measured before and during activity to track cardiovascular changes during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory rate
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Respiratory rate (respiratory cycles per minute) measured before and during activity to track changes in respiratory function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate variability (HRV)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Interval (in milliseconds) between consecutive heartbeats measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in electrodermal activity (EDA)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Electrical conductance (in microsiemens -µS) between two points of the hand over time measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential amplitude through surface electromyography (sEMG)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Muscle action potential amplitude (in millivolts - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential duration through surface electromyography (sEMG)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Muscle action potential duration (in milliseconds - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential frequency through surface electromyography (sEMG)
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Muscle action potential frequency (in hertz - Hz) of surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory pattern through inertial motion units (IMU) from baseline and during activity
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Angular range of motion (in degrees) of rib cage and abdominal wall during upper limb activity measured before and during activity to track changes in respiratory pattern during activity
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in upper limb motion angular acceleration through inertial motion units (IMU) system
Временное ограничение: From baseline to end of activity, up to 15 minutes
|
Angular acceleration (in m/s^2) of the arm measured before and during activity to track small movements of upper limb during isometric activity
|
From baseline to end of activity, up to 15 minutes
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Health Status
Временное ограничение: Before isometric activity
|
Health Status will be measured with Medical Outcomes Study (MOS) Short Form Health Survey 36 Item version 2 which measure health status of populations and individuals.
Possible scores range from 0 0 (worst health status) to 100 (best health status).
|
Before isometric activity
|
|
Physical activity level
Временное ограничение: Before isometric activity
|
Physical activity level will be measured using European Prospective Investigation into Cancer and Nutrition Physical Activity Questionnaire (EPIC-PAQ) that allows to estimate energy expenditure through self-report assessment of the intensity and average duration (per day, week and month) of physical activity performed by the participants in three distinct dimensions (professional, domestic and leisure). Participants are classified as ACTIVE if they perform: at least 150 minutes per week of moderate physical activity; OR at least 75 minutes per week of vigorous physical activity; OR at least 150 minutes per week of a combination of moderate-intensity activity. If they don't present any of the conditions described, they will be categorized as SEDENTARY. |
Before isometric activity
|
Соавторы и исследователи
Следователи
- Директор по исследованиям: Daniel López López, PhD, Universidade da Coruña
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- ESSCVP_FIS01/2021
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
продукт, произведенный в США и экспортированный из США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .